栄研化学(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4549/E00961 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/07/20 | 日証協 | 398,547株 | 0% | 382,225株 | 0% | 409,335株 | 0% | 113,151株 | 0% |
2018/07/13 | 日証協 | 375,068株 | +9.48% | 256,799株 | -49.21% | 340,439株 | +18.62% | 136,233株 | +154.73% |
2018/07/06 | 日証協 | 342,583株 | -8.73% | 505,561株 | +273.89% | 287,006株 | -12.33% | 53,482株 | -40.56% |
2018/06/29 | 日証協 | 375,339株 | -10.88% | 135,215株 | -55.18% | 327,368株 | -11.54% | 89,984株 | +20.24% |
2018/06/22 | 日証協 | 421,151株 | -12.05% | 301,673株 | -15.79% | 370,073株 | -7.31% | 74,835株 | +121.96% |
2018/06/15 | 日証協 | 478,831株 | -10.45% | 358,249株 | -5.36% | 399,241株 | -7.02% | 33,716株 | -66.47% |
2018/06/08 | 日証協 | 534,729株 | -3% | 378,532株 | +6.57% | 429,381株 | +0.27% | 100,568株 | +81.38% |
2018/06/01 | 日証協 | 551,262株 | -11.93% | 355,205株 | +61.65% | 428,241株 | -9.83% | 55,445株 | +2.38% |
2018/05/25 | 日証協 | 625,954株 | -4.25% | 219,731株 | -52.47% | 474,945株 | -7.42% | 54,155株 | -4.42% |
2018/05/18 | 日証協 | 653,705株 | +3.02% | 462,291株 | -1.96% | 513,007株 | +7.38% | 56,657株 | -38.71% |
2018/05/11 | 日証協 | 634,545株 | +8.73% | 471,548株 | +132.45% | 477,750株 | +6.23% | 92,439株 | +806.26% |
2018/05/02 | 日証協 | 583,591株 | -1.3% | 202,857株 | -16.52% | 449,745株 | -2.57% | 10,200株 | -71.19% |
2018/04/27 | 日証協 | 591,257株 | +6% | 243,000株 | +11.05% | 461,611株 | -0.41% | 35,402株 | +73.54% |
2018/04/20 | 日証協 | 557,779株 | -9.39% | 218,829株 | -55.5% | 463,513株 | -12.36% | 20,400株 | -73.33% |
2018/04/13 | 日証協 | 615,608株 | +26.09% | 491,803株 | +54.13% | 528,872株 | +8.32% | 76,480株 | -24.96% |
2018/04/06 | 日証協 | 488,220株 | +115.07% | 319,083株 | +50.94% | 488,244株 | +105.62% | 101,916株 | -45.77% |
2018/03/30 | 日証協 | 227,000株 | -12.71% | 211,403株 | +122.21% | 237,447株 | -7.78% | 187,947株 | +302.08% |
2018/03/23 | 日証協 | 260,061株 | -5.28% | 95,137株 | -56.47% | 257,469株 | -5.71% | 46,744株 | -26.99% |
2018/03/16 | 日証協 | 274,565株 | +11.66% | 218,538株 | +63.39% | 273,067株 | -6.7% | 64,020株 | -1.07% |
※株式分割は考慮していませんのでご注意ください。
Page Top